Could a new vaccine stop genital herpes? early trial underway
NCT ID NCT05432583
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This early-stage trial tests an investigational vaccine designed to prevent genital herpes lesions caused by HSV-2 (and possibly HSV-1). About 318 adults aged 18–55 will receive different doses of the vaccine or a placebo to check safety and immune response. The study is active but not recruiting, and results will help determine if the vaccine is safe and worthy of further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENITAL HERPES SIMPLEX TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accellacare PMG Research Wilmington LLC
Wilmington, North Carolina, 28401, United States
-
Accellacare Raleigh Medical Group
Raleigh, North Carolina, 27609, United States
-
Alliance for Multispecialty Research, LLC
Tempe, Arizona, 85281, United States
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Great Lakes Clinical Trials - Flourish Research
Chicago, Illinois, 60640, United States
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.